Log in
Enquire now

List of National Institutes of Health patents

List of National Institutes of Health patents
List of Sungwoo Hitech Co. Ltd. patents
List of L'Oreal Alumni Official Association patents
List of TauTona Group patents
Films directed by Andy Tennant
List of companies in Space Angels's investment portfolio
Patents where
Current Assignee
Name
is
National Institutes of HealthNational Institutes of Health
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 8119691 Method for treating airway hyper-responsiveness with lipoxin analogs

Patent 8119691 was granted and assigned to National Institutes of Health on February, 2012 by the United States Patent and Trademark Office.

National Institutes of Health
National Institutes of Health
United States Patent and Trademark Office
United States Patent and Trademark Office
8119691
February 21, 2012
‌
US Patent 8188032 G-CSF transferrin fusion proteins

Patent 8188032 was granted and assigned to National Institutes of Health on May, 2012 by the United States Patent and Trademark Office.

National Institutes of Health
National Institutes of Health
United States Patent and Trademark Office
United States Patent and Trademark Office
8188032
May 29, 2012
‌
US Patent 11215616 Methods of determining patient populations amenable to immunomodulatory treatment of cancer

Patent 11215616 was granted and assigned to National Institutes of Health on January, 2022 by the United States Patent and Trademark Office.

National Institutes of Health
National Institutes of Health
United States Patent and Trademark Office
United States Patent and Trademark Office
11215616
January 4, 2022
‌
US Patent 10040822 Neuroprotective composition and method of use

Patent 10040822 was granted and assigned to National Institutes of Health on August, 2018 by the United States Patent and Trademark Office.

National Institutes of Health
National Institutes of Health
United States Patent and Trademark Office
United States Patent and Trademark Office
10040822
August 7, 2018
‌
US Patent 10660890 Treatment of polycystic diseases with an HDAC6 inhibitor

Patent 10660890 was granted and assigned to National Institutes of Health on May, 2020 by the United States Patent and Trademark Office.

National Institutes of Health
National Institutes of Health
United States Patent and Trademark Office
United States Patent and Trademark Office
10660890
May 26, 2020
‌
US Patent 10121645 Sheathless interface for capillary electrophoresis/electrospray ionization-mass spectrometry

Patent 10121645 was granted and assigned to National Institutes of Health on November, 2018 by the United States Patent and Trademark Office.

The University of Kansas
The University of Kansas
National Institutes of Health
National Institutes of Health
United States Patent and Trademark Office
United States Patent and Trademark Office
10121645
November 6, 2018
‌
US Patent 11666569 Treatment of polycystic diseases with an HDAC6 inhibitor

Mayo Foundation for Medical Education and Research (MFMER)
Mayo Foundation for Medical Education and Research (MFMER)
National Institutes of Health
National Institutes of Health
United States Patent and Trademark Office
United States Patent and Trademark Office
11666569
June 6, 2023
7 results
0 selected
7 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us